Navigation Links
Cure for common cold,,

The cure for the common cold remains as elusive as ever. A federal advisory committee recommended recently that the first drug aimed at treating the cause of the cold// rather than just its symptoms not be approved.

In a unanimous decision, the Food and Drug Administration’s advisory panel on anti-viral drugs said there were too many questions about the safety of the drug, which is made by ViroPharma Inc., to allow its widespread use merely to treat an ail-away by itself. The drug, known as Picovir, has attracted attention because it directly attacks a family of viruses, known as picornavirus, that cause half or more of the billion colds caught in the US each year. The drug lodges into a pocket in the virus’ coat, interfering with the germ’s ability to infect cells and make copies of itself. Other cold remedies merely suppress symptoms, like drying runny noses or coughs. In clinical trials, Picovir shortened the length of the cold to roughly six days from seven. Patients took the pills three times a day for five days. First treatment, however, has to start within 24 hours of onset of symptoms, which some panel members said might be difficult for a drug that would be sold by prescription. The major concern, was that Picovir appeared to lower the effectiveness of oral contraceptives, which might cause inadvertent pregnancies. Some women taking both Picovir and birth control pills experienced bleeding between their menstrual periods. The panel also questioned whether the drug could be used by the general population because the participants in the clinical trial were mainly young, white, otherwise healthy women.

'"/>




Page: 1

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Iron supplementation for a common side effect
3. E. coli strains resistant to a common antibiotic
4. Gastrointestinal ills more common in diabetics
5. Toxic effects common with AIDS treatments
6. Drooping eyelids more common in men
7. Unnatural death common in mentally ill
8. New Drug, Pleconaril speeds recovery from common cold
9. Relief from common back pain
10. Drugs control and industry departments to share a common e-platform
11. Periodontitis a common problem in patients with arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... The Ellis Agency, an eastern ... Epilepsy Foundation in a community wide charity event with the goal of bringing in ... young local woman who lives with epilepsy, recently launched a charity campaign of her ...
(Date:7/21/2017)... ... 2017 , ... The Karen Miller Agency, a central Alabama ... greater Birmingham area, is joining the Chris Hammond Youth Foundation in a charity ... , The Chris Hammond Youth Foundation maintains athletic facilities in rural areas that ...
(Date:7/21/2017)... Grove, Ill. (PRWEB) , ... July 21, 2017 , ... ... & Fabric Liquid eco-friendly odor-control solution for colleges and universities at the ... safely and effectively eliminate severe cannabis and tobacco smoke odors without the use of ...
(Date:7/21/2017)... ... ... Hospital M&A activity slowed in the second quarter of 2017, according to new ... in the second quarter, up 15% from the 20 publicly announced acquisitions in the ... year-ago second quarter. Only four of the transactions disclosed a purchase price in the ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed a ... ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand ... Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it is ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... PARK, N.C. , July 10, 2017 ... $5m Convertible Note to support the development of CRISPR-Cas3 ... Tencent Holdings Limited, a leading Chinese Internet services provider, ... funding will advance multiple infectious disease product programs targeting ... Founded by Dr. Rodolphe ...
(Date:7/5/2017)... July 5, 2017   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade cell and tissue ... media ("BioLife"), today announced that it has reached an ... and largest shareholder, to modify its existing credit facility ... the modification, WAVI agreed to exchange its existing $4.25 ...
Breaking Medicine Technology: